Pathogenesis and treatment of bile duct loss after liver transplantation

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 8, Issue 4, 2001, Pages 316-322

  Inomata, Yukihiro ^a   Tanaka, Koichi ^b  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Chronic rejection; Ductopenia; Immunosuppression; Vanishing bile duct syndrome

Indexed keywords

ADOLESCENT; ADULT; BILE DUCT; BILE DUCT DISEASE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; INFANT; LIVER TRANSPLANTATION; MALE; PATHOLOGY; PRESCHOOL CHILD; REVIEW; SYNDROME;

ADOLESCENT; ADULT; BILE DUCT DISEASES; BILE DUCTS; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; SYNDROME; TRANSPLANTATION IMMUNOLOGY;

EID: 0035223960     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340170003     Document Type: Article

References (28)

1. An international panel (2000) Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 31:792-799
2. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ. Ruppert K, Abu-Elmaqd K, Mursh W, Madariaga J, Mazarieqos G, Geller D, Bonham CA, Gayowski T, Cacciarelli T, Fontes P, Starzl TE, Fung JJ (2000) Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 232:490-500
3. Demetris AJ, Murase N, Lee RG, Randhawa P, Zeevi A. Pham S, Duquesnoy R, Fung JJ, Starzl TE (1997) Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 2:27-44
4. Porte RJ, Ploeg RJ, Hansen B, van Bockel JH, Thoroqood J, Persijn GG, Hermans J, Terpstra OT (1998) Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicenter Study Group. Transpl Int 11 (Suppl 1):S164-S167
5. Demetris AJ (1998) Immune cholangitis: liver allograft rejection and araft-versus-host disease. Mayo Clinic Proc 73:367-379
6. Gapany C, Zhao M, Zimmermann A (1997) The apoptosis protector, bcl2 protein, is downregulatcd in bile duct epithelial cells of human liver allografts. J Hepatol 26:535-542
7. Vierling JM (1999) Immunology of acute and chronic hepatic allograft rejection. Liver Transpl Surg 5:S1-S20
8. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA (1987) The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7:476-483
9. Crawford AR, Lin XZ, Crawford JM (1998) The normal adult human liver biopsy: a quantitative reference standard. Hepatology 28:323-331
10. Minamiguchi S, Sakurai T, Fujita S, Okuno T, Haga H, Mino M, Kanehira K, Matsushiro H, Nakashima Y, Inomata Y, Tanaka K, Yamabe H (1999) Living related liver transplantation: histopathological analysis of graft dysfunction in 304 patients. Human Pathol 30:1479-1487
11. Demetris AJ, Seaberg EC, Batts KP, Ferrell L, Lee RG, Markin R, Detre KM (1998) Chronic liver allograft rejection. A National Institute of Diabetes and Digestive and Kidney Disease interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. Am J Surg Pathol 22:28-39
12. Demetris AJ (2000) Spectrum of chronic hepatic allograft rejection and arteriopathy and the controversy of centrilobular necrosis. Liver Transpl 6:102-103
13. An international Panel (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25:658-663
14. Wiesner RH, Batts KP, Krom AF (1999) Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transpl Surg 5:388-400
15. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD (1991) Chronic rejection after liver transplantation: a study of clinical histopathologic and immunological features. Hepatology 13:882-891
16. Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA, Moore SB, Ludwig J, Smith TE (1992) Lack of association of between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology 16:66-70
17. Evans PC, Coleman N, Wreghitt TG, Wight DGD, Alexander GJM (1999) Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol 31:913-920
18. Donaldoson P, Underhill J, Doherty D, Hagller K, Calne R, Tan KC, O'Grady J, Wight D, Portmann B, Williams R (1993) Influence of human leucocyte antigen matching on liver allograft survival and rejection: "the dualistic effect." Hepatology 17:1008-1015
19. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM (1995) Sex-mismatch as a risk factor for chronic rejection of liver allografts. Lancet 346:1117-1121
20. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM (1995) Timing, significance, and prognosis of late acute allograft rejection. Transplantation 60:1098-1103
21. Hubscher SG, Buckles JAC, Elias E, McMaster P, Neuberger J (1991) Vanishing bile duct syndrome following liver transplantation - is it reversible? Transplantation 51:1004-1009
22. Blakolmer K, Seaberg EC, Batts K, Ferrell L, Markin R, Wiesner R, Detre K, Demetris A (1999) Analysis of the reversibility of chronic liver allograft rejection: implications for a staging schema. Am J Surg Pathol 23:1328-1339
23. Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris AJ (2000) Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression. Long-term follow-up and evaluation of features for histopathological staging. Transplantation 69:2330-2336
24. McDirmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW (1995) The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 20:291-299
25. European FK506 multicenter liver study group (1994) Randomized trail comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423-428
26. US Multicenter Liver Study Group (1997) Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation. Transplantation 64:258-263
27. Klupp J, Bechstein WO, Platz KP, Keck H, Lemmens HP, Knoop M, Langrehr JM, Neuhaus R, Pratschke J, Neuhaus P (1997) Mycophenolate mofetil added to immunosuppression after liver transplantation - first results. Transplant Int 10:223-228
28. McDirmid SV (1996) Mycophenolate mofetil in liver transplantation. Clin Transplantation 10:140-145